Quantum-Si Reports Q1 2026 Results: Revenue Plunges 69% Amid Proteus Launch Anticipation, EPS Beats Estimates

summarizeSummary

Quantum-Si Inc. reported a significant 69.4% year-over-year revenue decline to $258,000 for Q1 2026, primarily due to customer deferrals ahead of its Proteus platform launch, while its net loss increased to $21.7 million, though EPS of $(0.10) beat analyst expectations.

check_boxKey Events

• Q1 2026 Revenue Plunges 69%

  Total revenue decreased 69.4% year-over-year to $258,000, primarily driven by lower sales volumes of instruments and consumables as customers deferred purchasing decisions in anticipation of the Proteus platform launch.

• Net Loss Increases, EPS Beats Estimates

  Net loss increased to $21.7 million for Q1 2026 from $19.2 million in Q1 2025. However, basic and diluted net loss per share of $(0.10) was better than the $(0.11) loss expected by analysts.

• Liquidity Position and Cash Burn

  The company held $190.4 million in cash, cash equivalents, and marketable securities as of March 31, 2026. Net cash used in operating activities for the quarter was $25.6 million, with management stating current liquidity is sufficient for at least the next twelve months.

• Legal Settlement Finalized

  A Delaware Stockholder Litigation was settled on March 27, 2026. The company paid $3.0 million, with the remaining $4.6 million of the $8.0 million liability funded by insurance proceeds, resolving this contingency.

auto_awesomeAnalysis

Quantum-Si Inc.'s first-quarter 2026 financial results show a substantial 69.4% year-over-year decline in total revenue to $258,000. This significant drop is primarily attributed to customers deferring purchases in anticipation of the Proteus next-generation platform, which is expected to launch by the end of 2026. This indicates a material near-term operational challenge and potential continued revenue headwinds. While the net loss increased to $21.7 million, the reported basic and diluted net loss per share of $(0.10) was better than the $(0.11) loss expected by analysts, offering a mixed signal. The company reported $190.4 million in cash, cash equivalents, and marketable securities, which management believes is sufficient to fund operations for at least the next twelve months. Additionally, a Delaware Stockholder Litigation was finalized, resolving a prior $8.0 million liability. Investors should closely monitor the Proteus launch and its subsequent impact on sales and market adoption.